 |
|
|
|
|
|
|
|
|
|
|
|
1 to 10 of 10 results |
|
 |
|
|
|
|
|
 |
|
|
|
|
Green A, Rebeck G. on NEWS: Does ApoE4 Risk Begin in the Womb?, This is a very interesting study looking at an incredible dataset of MRI scans from 272 infants.... 8 Jan 2013.
|
|
|
 |
|
|
Rebeck G. on PAPER: Ranganathan S. et al., 2011, This work from Dudley Strickland's lab describes a new protein related to the LDL receptor... 1 Aug 2011.
|
|
|
|
|
|
Rebeck G. on PAPER: Castellano JM. et al., 2011, This paper provides really compelling data that one role of ApoE in AD pathogenesis is by... 7 Jul 2011.
|
|
|
|
|
|
Rebeck G. on PAPER: Zhang Y. et al., 2010, Zhang et al. have published a very interesting study showing that deletion of the... 24 Oct 2010.
|
|
|
|
|
|
Rebeck G. on NEWS: Reelin, Aβ, α7 Play Yin and Yang Around NMDA Receptors, Comment on Herz et al.
This work addresses an exciting target in therapeutic... 4 Sep 2009.
|
|
|
|
|
|
Rebeck G. on NEWS: Anne Cataldo, 57, Autophagy Researcher Known for Generous Collegiality, The last time I saw Anne, I stopped by unannounced in her lab at McLean. She was talking to... 27 Apr 2009.
|
|
|
|
|
|
Rebeck G. on PAPER: Deane R. et al., 2008, APOE is the strongest genetic risk factor for late onset Alzheimer’s disease. In the brain,... 9 Dec 2008.
|
|
|
|
|
|
Rebeck G. on PAPER: Sano Y. et al., 2006, Several groups have found that X11 and X11L1 interact with APP, affect APP metabolism, and... 31 Oct 2006.
|
|
|
|
|
|
Rebeck G. on PAPER: Andersson S. et al., 2005, LXR¹s are nuclear hormone receptors that bind to hydroxylated forms of cholesterol and promote... 4 Mar 2005.
|
|
|
|
|
|
Rebeck G. on NEWS: It’s a RAP—Loss of LRP Increases Amyloid Deposition in Mice, Over the last 10 years, numerous studies have indicated that the low-density lipoprotein... 2 Nov 2002.
|
|
|
|
|
|
|
1 to 10 of 10 results |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
The ALS Forum is a web-based collaborative effort to bring together valuable ALS-related resources for use by researchers worldwide in both academia and industry-based settings.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Should the FDA be allowed to use data from overseas clinical trials? |
|
|
|
|
|
|
|
|
|
|
|
Absolutely, we are running out of viable subjects in the U.S. |
|
|
|
|
|
|
 9 |
|
|
|
|
|
|
|
|
|
|
|
Yes, so long as the data is reliable |
|
|
|
|
|
|
31 |
|
|
|
|
|
|
|
|
|
|
|
No, the trials are not as rigorous |
|
|
|
|
|
|
3 |
|
|
|
|
|
|
|
|
|
|
|
No, the data should be repeated in the U.S. |
|
|
|
|
|
|
5 |
|
|
|
|
|
|
|
|
|
|
|
No, the drug sponsors are just trying to cut corners |
|
|
|
|
|
|
3 |
|
|
|
|
|
|
|
|
|
|
|
Responses: 51 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
Archived Polls |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
 Antibodies
Cell Lines
Collaborators
Papers
Research Participants
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Home
See our latest Webinar: 
